Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LMO4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C4orf19 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RTF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
LARGE1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFIT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MED13L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD226 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DIAPH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTATIP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAPK8IP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INPP5K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NPR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
A1CF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM44 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACRV1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NT5M - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC1A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
JAG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on